# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-012859
Filing Date
2024-04-02
Accepted
2024-04-02 17:22:03
Documents
7
Period of Report
2024-04-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formpre14a.htm | PRE 14A | 977025
2 |  | ba_logo1.jpg | GRAPHIC | 23568
3 |  | formpre14a_002.jpg | GRAPHIC | 1579
4 |  | formpre14a_004.jpg | GRAPHIC | 1574
5 |  | formpre14a_006.jpg | GRAPHIC | 1574
6 |  | proxy_001.jpg | GRAPHIC | 324514
7 |  | proxy_002.jpg | GRAPHIC | 266317
| Complete submission text file | 0001493152-24-012859.txt |  | 1831548

Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41463 | Film No.: 24815671
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)